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Case Reports
Transcatheter Occlusion of Large Pulmonary
Arteriovenous Malformations Using Multiple Devices
in a Neonate
Rajiv Devanagondi,1 MD, Jason B. Tapio,2 RN, and Ronald G. Grifka,1* MD
Pulmonary arteriovenous malformations (PAVMs) are usually well-tolerated hemody-
namically. Rarely, they cause severe neonatal cyanosis, requiring urgent treatment. We
report the use of multiple transcatheter vascular occlusion devices to reduce right-to-
left shunting in a neonate with multiple, large PAVMs. VC 2014 Wiley Periodicals, Inc.
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INTRODUCTION
Pulmonary arteriovenous malformations (PAVMs)
are often diagnosed incidentally on a chest imaging
study and are well-tolerated hemodynamically. Rarely,
they present with severe neonatal cyanosis due to
right-to-left shunting. Historically, PAVM treatment
has included surgical segmental resection, lobectomy,
or pneumonectomy [1,2]. With advances in transcathe-
ter therapy, PAVM occlusion using embolization coils
has been established in infants as an effective alterna-
tive to surgical resection [3]. Also, the efficacy of vas-
cular plugs has been demonstrated in children, and
more recently in an infant [4,5]. We present a case of
multiple, large PAVMs requiring several transcatheter
occlusion devices for the treatment of profound neona-
tal cyanosis.
CASE REPORT
A 3.8 kg full term male infant presented with dysp-
nea and hypoxemia shortly after birth; room air sys-
temic oxygen saturation was 75%, which did not
improve with supplemental oxygen. Physical examina-
tion was notable for diminished right-sided breath
sounds and a 2/6 systolic ejection murmur at the left
mid-sternal border. There were no telangiectasias or
hemangiomas. A chest radiograph demonstrated mild
cardiomegaly, right middle and upper lobe opacities.
An echocardiogram demonstrated left atrial enlarge-
ment, small atrial septal defect with left-to-right shunt,
moderately diminished left ventricular systolic func-
tion, and a moderate sized patent ductus arteriosus
with left-to-right shunt; the intracardiac anatomy was
otherwise normal. A chest CT scan demonstrated mul-
tiple, large, complicated right-sided PAVMs. A head
CT scan was normal, without cerebral arteriovenous
malformations (AVMs) or intracranial hemorrhage.
Genetic studies for hereditary hemorrhagic telangiecta-
sia (HHT) were negative.
On the second day of life, the patient was referred
for cardiac catheterization to define the PAVM anat-
omy and for transcatheter PAVM occlusion. A
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selective right pulmonary artery angiogram demon-
strated two large PAVMs (Fig. 1A and B). The largest
PAVM (7.8 mm) was associated with the right middle
lobe pulmonary artery and bifurcated into two
moderate-large sized superior (4.5 mm) and inferior
(4.8 mm) PAVMs. The second large PAVM (6.6 mm)
was associated with the right upper lobe pulmonary ar-
tery and bifurcated into two smaller PAVMs. There
was markedly increased flow through these vessels,
with contrast returning through an enormously dilated
right upper pulmonary vein to the left atrium (Fig. 2).
The right lower pulmonary artery was small, but with-
out PAVMs. A left pulmonary artery angiogram dis-
played normal vasculature (Fig. 3).
A 5 Fr transseptal sheath was positioned in the right
middle lobe PAVM for vascular plug delivery. During
device delivery, with the transseptal sheath across the
tricuspid valve, there was transient, exacerbated hypox-
emia, which resolved promptly when the sheath was
withdrawn to the right atrium following deployment of
each device. The superior branch of the right middle
lobe PAVM was occluded with a 6 mm Amplatzer
Vascular Plug II (AVP II) (St. Jude Medical, St. Paul,
MN). As there was some residual flow through this de-
vice, an 8 mm AVP II was deployed just proximal to
the first device. The inferior branch of the right middle
lobe PAVM was occluded with two 8 mm AVP II
devices. The right upper lobe PAVM was occluded
with a 10 mm AVP II. A repeat angiogram in the right
pulmonary artery demonstrated no residual flow
Fig. 1. Right pulmonary artery angiogram in the PA (A) and
lateral (B) projections demonstrating two large PAVMs associ-
ated with the right upper and middle lobes. The right middle
lobe PAVM bifurcates into two large PAVMs. The right lower
lobe artery is small.
Fig. 2. A contrast injection reveals an enormous right upper
pulmonary vein draining to the left atrium.
Fig. 3. An angiogram is performed in the proximal left pul-
monary artery. The left pulmonary artery bifurcates normally;
no PAVMs or other abnormalities are noted.
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through the occluded PAVMs. However, following
occlusion of these large PAVMs, smaller PAVMs were
evident. A right upper lobe PAVM (2.9 mm) originated
just distal to the previously occluded right upper lobe
PAVM. A right middle lobe PAVM (3.2 mm) origi-
nated between the previously occluded superior and in-
ferior branches. A 4 Fr snare catheter was used to
deploy two 0.03800  4 cm  3 mm MReye emboliza-
tion coils (Cook, Bloomington, IN) in two small right
upper lobe PAVMs (Fig. 4). The snare catheter was
positioned in the right middle lobe PAVM to deploy a
0.03800  5 cm  5 mm MReye embolization coil.
Two more proximal, small PAVMs were identified
arising from the right middle lobe pulmonary artery,
and each was occluded with a 0.03800  4 cm  3 mm
MReye embolization coil. At the conclusion of the pro-
cedure, his systemic arterial oxygen saturation was
90% while receiving FiO2 35%. He weaned promptly
from mechanical ventilation, extubated easily, and dis-
charged home one week following the catheterization
with a systemic oxygen saturation of 88% in room air.
He was evaluated monthly in the Pediatric Cardiol-
ogy clinic, and his oxygen saturation rose gradually to
95%. However, over several months this declined to
85%. At age 7 months, he returned to the cardiac cath-
eterization lab for diagnostic catheterization and occlu-
sion of additional PAVMs. A selective left pulmonary
artery angiogram was normal. A right pulmonary artery
angiogram demonstrated no flow through the previ-
ously placed, well positioned occlusion devices. There
was a large right middle lobe PAVM (5.5 mm) (Fig.
5). This was occluded with a 6 mm AVP II. As there
was residual flow through this device, an 8 mm AVP
II was placed just proximal to the 6 mm device. A
follow-up angiogram demonstrated several small ves-
sels, arising proximal to these plugs, supplying this
large PAVM. Two 0.03800  4 cm  3 mm MReye
embolization coils were deployed to occlude the small
tributary vessels. A right pulmonary artery angiogram
demonstrated complete occlusion of the large right
middle lobe PAVM and small tributary vessels (Fig.
6A and B). There was flow through a small right upper
lobe PAVM; however stable catheter positioned could
not be maintained for coil delivery. His systemic oxy-
gen saturation, which was 85% at the start of the cath-
eterization, improved to 92% at the conclusion of the
procedure. He extubated easily, recovered uneventfully,
and was discharged home the following day.
The most recent evaluation was at age 36 months.
He has not required any interventions. He is growing
and developing normally (weight> 95th percentile for
age), with a normal respiratory and cardiovascular ex-
amination, and systemic oxygen saturation 93% in
room air. Chest radiograph demonstrated normal heart
size, normal pulmonary vascular markings in the left
lung and right lower lobe, occlusion devices in stable
position in the right middle and right upper lobes, and
interval decrease in the size of the enlarged right upper
pulmonary vein. The oxygen saturation of 93%,
although markedly improved, suggests persistence of
small PAVMs.
DISCUSSION
The differential diagnosis for neonatal cyanosis
encompasses many illnesses. In the presence of hypox-
emia refractory to oxygen and the absence of congeni-
tal heart defects with right-to-left shunting or severe
neonatal respiratory disease, congenital PAVM should
be considered. Embryologically, PAVMs result from
Fig. 4. Following vascular plug deployment in the right upper
and right middle lobe AVMs, and placement of two coils in
the right upper lobe AVM, there is still contrast flow through
residual AVMs, mostly associated with the right middle lobe.
Fig. 5. Right pulmonary artery angiogram at age 7 months
demonstrates a new, large right middle lobe PAVM.
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persistent pulmonary arteriovenous connections without
an intervening capillary bed, due to incomplete vascu-
lar septae development between primitive pulmonary
arteries and venous plexuses [6]. Physiologically,
PAVMs are low resistance channels through which
blood is preferentially shunted, bypassing capillary gas
exchange, resulting in an intrapulmonary right-to-left
shunt. This leads to hypoxemia, polycythemia, and risk
for paradoxical embolism. Though rare, neonates that
are symptomatic due to PAVMs can be critically ill, as
in our case, presenting with profound cyanosis and
dyspnea, as well as congestive heart failure or lung
hemorrhage. Mortality is high, up to 39% in the first
week of life; 33% of these infants were suspected to
have HHT [7].
Between 47% and 80%, all congenital PAVMs are
associated with HHT; conversely, the incidence of
PAVM in all patients with HHT is 5–15% [8]. The diag-
nosis of HHT is made clinically based on the presence
of 3 of 4 Curac¸ao Criteria: epistaxis, telangiectasia, vis-
ceral AVM, or positive family history. While our patient
does not meet diagnostic criteria for HHT, a high degree
of suspicion is required to diagnose HHT in a newborn,
as clinical findings are often absent until later in life.
Genetic testing can be helpful in infants with a family
history of HHT with a known mutation. Genetic testing
in the absence of a family history of HHT is not as sen-
sitive, as these patients often have novel mutations in the
ENG or ACVRL1 genes [9]. Determining HHT status in
neonates with PAVM is important, as patients with HHT
are more likely to have multiple PAVMs, more rapid
disease progression, and more complications [8]. While
uncommon, cerebral AVM in infants with HHT is espe-
cially concerning, as intracranial hemorrhage in this pop-
ulation is almost universally fatal [10].
Prior to 1994, surgical resection, lobectomy, or total
pneumonectomy was recommended for symptomatic
neonatal PAVM [2,11]. Transcatheter occlusion of neo-
natal PAVM using Gianturco stainless steel coils was
first described by Grady et al [3]. Transcatheter occlu-
sion is preferable to surgical resection to avoid surgical
morbidity and mortality. Also, by selectively emboliz-
ing the abnormal vasculature, the normal pulmonary
vasculature is preserved.
Our case emphasizes the importance of a persistent
and thorough catheterization evaluation, and using vari-
ous types of occlusion devices, depending on vessel size
and morphology, to occlude as many PAVMs as possi-
ble. We used MReye embolization coils and the AVP
II. While use of the Amplatzer Vascular Plug has been
described in the occlusion of PAVMs in older children,
and recently in one neonate, to our knowledge the AVP
II has not been described for the treatment of neonatal
PAVM [4,5]. The AVP II is advantageous in large
PAVM occlusion, due to its stability in high flow ves-
sels and rapid embolization properties [12]. The recently
released lower profile AVP 4 can be delivered through
a catheter with 0.03800 inner diameter, as opposed to a
larger sheath. Using the AVP 4 may have prevented the
transient oxygen desaturation during device delivery in
our patient. However, given the recommendation for
30% device oversizing, the largest AVP 4 (8 mm),
might not have occluded the largest PAVM in our
patient [13]. Additionally, this case reinforces the impor-
tance of assiduous clinical follow-up. As has been
described previously, and noted in our case, these
patients may have residual PAVMs or develop enlarge-
ment of previously minor PAVMs, necessitating re-
intervention [11,14]. In one large series, 19% of patients
developed significant enlargement of feeding arteries to
previously small PAVMs, and 7% developed
Fig. 6. Right pulmonary artery angiogram in PA (A) and lat-
eral (B) projections demonstrates occlusion of right middle
lobe PAVM and tributary vessels, with small residual right
upper lobe PAVM.
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recanalization of previously occluded PAVMs, usually
through embolization coils [15]. Serial occlusion of
PAVMs facilitates the detection of smaller malforma-
tions which have the potential to become hemodynami-
cally significant over time. Also, this technique
promotes growth of the normal pulmonary vasculature.
In our patient, the normal, but small, right lower lobe
pulmonary artery has grown following occlusion of the
PAVMs. Normal pulmonary artery branches are now
visible in the right middle and upper lobes. Clinical
follow-up is ongoing, as the systemic oxygen saturation
of 93% suggests residual small PAVMs, along with
evaluation for signs and symptoms of HHT.
CONCLUSION
PAVM is a rare, though treatable and reversible cause
of marked cyanosis in neonates. In all cases, an evalua-
tion should be performed for extra-PAVMs, especially
cerebral AVM and HHT. Over the last decade, several
transcatheter vascular occlusion devices have become
available, and are especially useful for treating neonatal
PAVMs. Careful angiographic evaluation of vessel size
and morphology ensures use of the best device for each
lesion. Serial clinical follow-up evaluations are required
after initial treatment, as additional interventions may be
required to treat persistent, enlarging, or new PAVMs,
as noted by recurrent hypoxemia or other sequelae.
REFERENCES
1. Gomes MR, Bernatz PE, Dines DE. Pulmonary arteriovenous
fistulas. Ann Thorac Surg 1969;7:582–593.
2. Ravasse P, Maragnes P, Petit T, Laloum D. Total pneumonec-
tomy as a salvage procedure for pulmonary arteriovenous mal-
formation in a newborn: Report of one case. J Pediatr Surg
2003;38:254–255.
3. Grady RM, Sharkey AM, Bridges ND. Transcatheter coil embo-
lisation of a pulmonary arteriovenous malformation in a neo-
nate. Br Heart J 1994;71:370–371.
4. Yim D, D’Orsogna L. Occlusion of a large pulmonary arteriove-
nous malformation in a paediatric patient using multiple vascu-
lar plugs. Heart Lung Circ 2010;19:257–259.
5. Celebi A, Yucel IK, Dedeoglu R, Erdem A. Echocardiographic
diagnosis and transcatheter occlusion of pulmonary arteriove-
nous fistula in cyanotic newborn. Congenit Heart Dis 2013;8:
E188–E191.
6. Anabtawi IN, Ellison RG, Ellison LT. Pulmonary arteriovenous
aneurysms and fistulas. Anatomical variations, embryology, and
classification. Ann Thorac Surg 1965;122:277–285.
7. Gludovacz K, Vlasselaer J, Mesens T, Van Holsbeke C, Van
Robays J, Gyselaers W. Early neonatal complications from pul-
monary arteriovenous malformations in hereditary hemorrhagic
telangiectasia: Case report and review of the literature. J Matern
Fetal Neonatal Med 2012;25:1494–1498.
8. Khurshid I, Downie GH. Pulmonary arteriovenous malforma-
tion. Postgrad Med J 2002;78:191–197.
9. Faughnan ME, Palda VA, Garcia-Tsao G, Geisthoff UW,
McDonald J, Proctor DD, Spears J, Brown DH, Buscarini E,
Chesnutt MS, Cottin V, Ganguly A, Gossage JR, Guttmacher
AE, Hyland RH, Kennedy SJ, Korzenik J, Mager JJ, Ozanne
AP, Piccirillo JF, Picus D, Plauchu H, Porteous ME, Pyeritz
RE, Ross DA, Sabba C, Swanson K, Terry P, Wallace MC,
Westermann CJ, White RI, Young LH, Zarrabeitia R. Interna-
tional guidelines for the diagnosis and management of heredi-
tary haemorrhagic telangiectasia. J Med Genet 2011;48:73–87.
10. Delaney HM, Rooks VJ, Wolfe SQ, Sawyer TL. Term neonate
with intracranial hemorrhage and hereditary hemorrhagic telan-
giectasia: A case report and review of the literature. J Perinatol
2012;32:642–644.
11. Farra H, Balzer DT. Transcatheter occlusion of a large pulmo-
nary arteriovenous malformation using the Amplatzer vascular
plug. Pediatr Cardiol 2005;26:683–685.
12. Tabori NE, Love BA. Transcatheter occlusion of pulmonary ar-
teriovenous malformations using the Amplatzer Vascular Plug
II. Catheter Cardiovasc Interv 2008;71:940–943.
13. Ferro C, Rossi UG, Bovio G, Petrocelli F, Seitun S. The
Amplatzer vascular plug 4: Preliminary experience. Cardiovasc
Intervent Radiol 2010;33:844–848.
14. Fletcher SE, Cheatham JP, Bolam DL. Primary transcatheter
treatment of congenital pulmonary arteriovenous malformation
causing cyanosis of the newborn. Catheter Cardiovasc Interv
2000;50:48–51.
15. Pollak JS, Saluja S, Thabet A, Henderson KJ, Denbow N, White
RI Jr. Clinical and anatomic outcomes after embolotherapy of
pulmonary arteriovenous malformations. J Vasc Interv Radiol
2006;17:35–44; quiz 5.
434 Devanagondi et al.
Catheterization and Cardiovascular Interventions DOI 10.1002/ccd.
Published on behalf of The Society for Cardiovascular Angiography and Interventions (SCAI).
